- Nachrichtendetail
-
24.06.2024 13:15:52 - dpa-AFX: *BIONTECH, DUALITYBIO RECEIVE FDA FAST TRACK DESIGNATION FOR BNT324/DB-1311 IN PROSTATE CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BIONTECH SE SPON. ADRS 1 | A2PSR2 | Xetra | 74,200 | 12.08.24 12:47:23 | +1,550 | +2,13% | 74,150 | 74,350 | 73,750 | 72,650 |
